Regulating science and technology: The case of the UK biotechnology industry

Law and Policy

Volumn 27, Issue 1, 2005, Pages 189-212

  Smith, Helen Lawton ^a,b,c,d  

^a Department of Economics Finance and Accounting   (United Kingdom)

^b Faculty of Engineering and Computing   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27844599760     PISSN: 02658240     EISSN: 14679930     Source Type: Journal    
DOI: 10.1111/j.1467-9930.2004.00196.x     Document Type: Article

References (34)

1. Abraham, John (1997) "The Science and Politics of Medicines Regulation." In The Sociology of Medical Science and Technology, edited by M. A. Elston. Oxford: Blackwell Publishers.
2. Archibugi, Daniele, and Mario Pianta (1992) The Technological Specialisation of Advanced Countries. Dordrecht: Kluwer and OECD.
3. Battelle Memorial Institute and the State Science and Technology Institute (2001) State Government Initiatives in Biotechnology 2001. Columbus, Ohio: Battelle Memorial Institute.
4. Chen, Zhiqi, and Alison McDermott (1998) "International comparison of Biotechnology Policies," Journal of Consumer Policy 21: 527-50.
5. Cohen, Wesley (1995) "Empirical Studies of Innovative Activity." In Handbook of the Economics of Innovation and Technical Change, edited by P. Stoneman. Blackwell: Oxford.
6. Commission of the European Communities (EC) (2001) Towards a Strategic Vision of Life Sciences and Biotechnology, COM (2001) 454 final. Brussels: EC.
7. Commission of the European Communities (EC) (2002) Life Sciences and Biotechnology, COM (220) 27 final. Brussels: EC.
8. Cooke, Philip (2002) "Biotechnology Clusters as Regional, Sectoral Innovation Systems," International Science Review 25: 38-62.
9. Cooke, Philip (2003) "Biotechnology clusters, 'Big Pharma' and the Knowledge-Driven Economy," International Journal of Technology Management 25: 65-80.
10. Cooke, Philip (2004) Globalisation of Biosciences: Knowledge Capabilities and Economic Geography. Paper presented at the Centennial Conference of the Association of American Geographers, Philadelphia, 14-19 March.
11. Davis, Kay (2002) "Creating Knowledge - New Initiatives in Oxford." Seminar given "Genetics Knowledge in Oxford - Networks and Opportunities?," at Said Business School, Oxford, 30 October.
12. Ernst & Young (2003) Beyond Borders: The Global Biotechnology Report 2003. London: Ernst & Young.
13. Franklin, Sarah (1999) "What We Know and What We Don't Know about Cloning and Society," New Genetics and Society 18: 111-20.
14. Hall, Linda, and Sharmistha Bagchi-Sen (2001) "An Analysis of R&D, Innovation and Business Performance in the US Biotechnology Industry," International Journal of Biotechnology 3: 267-86.
15. Ince, M. (2000) "Genetic Data hits Consent Setback," Times Higher 18 February.
16. Gardner, Richard L. (2002) Therapeutic Cloning and Reproductive Cloning - a Scientific Perspective. Mimeo. Oxford: Oxford Univ. Department of Zoology.
17. Gill, David, Chris Martin, Tim Minshall, and Martin Rigby (2000) Funding Technology: Lessons from America. London: Wardour Communications.
18. Great Britain. Department of Trade and Industry (DTI) (2002) Metrology and the Biosciences. London: DTI.
19. Great Britain. Department of Trade and Industry (DTI) (2003) Bioscience 2015: Improving National Health, Increasing National Wealth. A Report to the Government by the Bioscience Innovation and Growth Team. London: DTI.
20. Great Britain. Department of Trade and Industry (DTI) (2004) 164.36.164.20/nms/prog/new/biotech0407prv.pdf
21. Great Britain. Office of Science and Technology (1999) The Advisory and Regulatory Framework for Biotechnology: Report from the Government's Review. London: Office of Science and Techology. Available at: http://www.ost.gov.uk/ policy/issues/biotech_report/.
22. Kim, Seok-Ran, and Nick von Tunzelmann (1998) Aligning Internal and External Networks: Taiwan's Specialization in IT. SPRU Electronic Working Paper 17, May. York: Social Policy Research Unit.
23. Lawton Smith, Helen (2000) Technology Transfer and Industrial Change in Europe Basingstoke: Macmillan.
24. Martin, Paul A., and Sandy M. Thomas (1998) "The Commercial Development of Gene Therapy in Europe and the USA," Human Gene Therapy 9: 87-114.
25. Martin, Ron, Peter Sunley, and Dave Turner (2002) "Taking Risks in Regions: The Geographical Anatomy of Europe's Emerging Venture Capital Market," Journal of Economic Geography 2: 121-50.
26. Oxford Trust (2002) Oxford Networks: Medical & Biosciences Report. Oxford: Oxford Trust.
27. Pammolli, Fabio, Massimo Riccaboni, Alfonso Gambardella, Myriam Mariani, and Luigi Orsenigo (2001) Innovation and Competitiveness in the European Biotechnology Industry. Report Commissioned by the European Commission, DG Enterprise, as a Background Paper for the Competitiveness Report 2001. Brussels: EC.
28. Radosevic, Slavo (2002) The Electronics Industry in Central and Eastern Europe: An Emerging Production Location in the Alignment of Networks Perspective. Centre for the Study of Economic and Social Change in Europe' School of Slavonic and East European Studies, University College London Working Paper no. 21. London: University College
29. Salter, Brian, and Michael E. Smith (2002) The UK's stake in the biotechnology debate: Global competition and regulatory politics. Working paper from current ESRC project, "The Governance of Human Genetics," funded by the ESRC as part of its Innovative Health Technologies Programme, University of East Anglia. Available at http://www.uea.ac.uk/~x514/research/govemance/ UK'sstakeinthebiotechnologydebate.pdf.
30. Salter, Brian, and Lynn Frewer (2002) The changing governance of biotechnology - the politics of public trust. Working paper from current ESRC project, "The Governance of Human Genetics," funded by the ESRC as part of its Innovative Health Technologies Programme, University of East Anglia. Available at http://www.uea.ac.uk/~x514/research/governance/BIOGOV3.pdf.
31. Smith, Keith (1987) "Economic Infrastructures and Innovation Systems." In Systems of Innovation: Technologies, Institutions and Organisations, edited by C. Edquist. London: Pinter.
32. Spallone, P., and Tom Wilkie (1999) "Social, ethical and public policy implications of advances in the biomedical sciences: the Wellcome Trust's initiative on pharmacogenetics." Paper presented to the European Workshop on Legal, Regulatory and Ethical Aspects in Pharmacogenetics, 12 November, Berlin.
33. Van Reenan, John (2002) Economic Issues for the U.K Biotechnology Sector. Lexcon/University College London Working Paper, February. Available at: http://www.lexecon.co.uk/profiles/articles/biotech5.pdf
34. Wellcome Trust (2000) Planning for the Future. London: The Wellcome Trust.